Bispham Barbara Harlin (CIK 2075230) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Sell CBIO (620 shares), Sell CBIO (1,218 shares), Buy CBIO (12,422 shares), Buy CBIO (6,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | CRESCENT BIOPHARMA, INC. (CBIO) | General Counsel and Corporate Secretary | Sell | 620 | $11,098 |
| 2026-06-23 | CRESCENT BIOPHARMA, INC. (CBIO) | General Counsel and Corporate Secretary | Sell | 1,218 | $21,912 |
| 2025-12-17 | CRESCENT BIOPHARMA, INC. (CBIO) | General Counsel and Corporate Secretary | Buy | 12,422 | $0 |
| 2025-12-17 | CRESCENT BIOPHARMA, INC. (CBIO) | General Counsel and Corporate Secretary | Buy | 6,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18